Federal Court Finalizes Consent Decree Against Philips Respironics
The decree mandates a recall remediation plan and production restrictions to address safety concerns following the widespread 2021 recall of CPAP and BiPAP machines.
The decree mandates a recall remediation plan and production restrictions to address safety concerns following the widespread 2021 recall of CPAP and BiPAP machines.
The FDA received over 270 reports related to thermal issues such as fire, smoke, burns, and other signs of overheating while patients are using Philips DreamStation 2 CPAP machines.
A small patient trial also suggests CPAP may be more effective than a weight-loss drug in tackling clogged arteries.
The new partnership adds Monaghan respiratory therapy products to Premier’s purchasing and supply chain system.
Read MoreThe Luna G3 Bilevel S/T 30Vt was granted 510(k) clearance by the US FDA for use as a noninvasive ventilator (NIV), according to manufacturer React Health.
Read MoreIn response to increased demands on oxygen equipment fleets, Caire has added Repair Authority to the company’s Authorized Service Center network.
Read MorePhilips Respironics has recalled certain CPAP and BiPAP masks containing magnets that may cause potential injuries or death when the magnets interfere with certain implanted metallic medical devices and metallic objects in the body, according to an FDA alert.
Read MoreCertain Philips BiPAP devices are being recalled due to the potential to release volatile organic compounds (VOCs), according to the FDA.
Read MoreMonaghan Medical Corp and the Children’s Hospital Association (CHA) have agreed to a three-year contract for Monaghan provide CHA members with devices in two categories: respiratory therapy medication delivery, and oscillatory positive expiratory pressure/positive airway pressure (OPEP/PAP).
Read MoreAt SLEEP 2022, SleepRes LLC introduced the V-Com, a CPAP accessory that the company...
Read MorePhilips Respironics: Submission of a medical device report itself is not evidence that the device caused or contributed to the adverse outcome or event.
Read MoreSomnics Health unveils iNAP, a new oral negative pressure therapy for obstructive sleep apnea (OSA) patients.
Read MoreFisher & Paykel Healthcare launches F&P Evora Full, a new full face CPAP mask, in the United States. Evora Full will be available for purchase by durable medical equipment companies starting May 9.
Read MoreSleep apnea sufferers can gain health benefits from PAP therapy (positive airway pressure) in as little as two hours per night, according to a study presented at ATS 2022.
Read MoreComputational modeling shows that noninvasive respiratory support is more likely to be successful if it allows significant reductions in patients’ breathing efforts.
Read More